Compare CLST & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLST | HYPR |
|---|---|---|
| Founded | 1922 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.8M | 83.2M |
| IPO Year | 2021 | 2021 |
| Metric | CLST | HYPR |
|---|---|---|
| Price | $17.90 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $1.59 |
| AVG Volume (30 Days) | 2.8K | ★ 358.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.79 | 23.21 |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $13,563,000.00 |
| Revenue This Year | N/A | $50.75 |
| Revenue Next Year | N/A | $29.71 |
| P/E Ratio | $59.67 | ★ N/A |
| Revenue Growth | N/A | ★ 5.22 |
| 52 Week Low | $13.15 | $0.75 |
| 52 Week High | $20.50 | $2.22 |
| Indicator | CLST | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 53.98 | 44.81 |
| Support Level | $16.28 | N/A |
| Resistance Level | $18.16 | $1.19 |
| Average True Range (ATR) | 0.39 | 0.04 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 32.93 | 69.25 |
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.